|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||1.42 - 1.45|
|52 Week Range||0.90 - 3.45|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 9, 2017 - Aug 14, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.00|
TheraCann International announces patent license agreement covering cannabis tracking and traceability
The Stony Brook, New York-based company said it had a loss of 12 cents per share. The DNA-based security technology company posted revenue of $647,700 in the period. Its adjusted revenue was $648,000. ...
Applied DNA Sciences, Inc. , announced financial results for the fiscal 2018 first quarter ended December 31, 2017.
NEW YORK, NY / ACCESSWIRE / February 8, 2018 / Applied DNA Sciences, Inc. (NASDAQ: APDN ) will be discussing their earnings results in their Q1 Earnings Call to be held on February 8, 2018 at 4:30 PM Eastern ...
Applied DNA Sciences, Inc. announced today that in conjunction with TheraCann International Benchmark Corporation, it has had early success in the tagging and authentication of legal cannabis and its derivatives in a laboratory pilot.
Applied DNA Sciences, Inc. , is pleased to report that SigNature DNA evidence has resulted in two new convictions, bringing the company’s total to 117.
Applied DNA Sciences, Inc. , today announced that in response to an order from an international cotton gin, the Company will be installing its patent-pending SigNature® T DNA Transfer System at an off-shore gin.
Applied DNA Sciences, Inc. , announced today it plans to release financial results for its fiscal 2018 first quarter ended December 31, 2017 after market close on Thursday, February 8, 2018.
Applied DNA Sciences, Inc. , today announced it is collaborating with GHCL, Limited , a global manufacturer of home textiles, and Reliance Industries Ltd.
Bitcoin and blockchain mania continue to dominate headlines, with many companies changing their entire business structure to accommodate the growing industry. Several companies announced blockchain-related ...
Applied DNA Sciences, Inc. today announced the signing of an initial two-year, $1 million contract with TheraCann International Benchmark Corporation, , a leading full service cannabis consultancy with operations in the US, Canada, Australia, Europe and South America, for the integration of the Company’s SigNature® molecular tagging and testing technology into TheraCann’s blockchain-based, seed-to-sale ...
Applied DNA Sciences, Inc. today announced the establishment of a Central DNA Testing Laboratory in Ahmedabad, India providing full forensic authentication services.
Applied DNA Sciences, Inc. , today announced it will introduce a GeoTyping™ Beta Program, for the month of February, to brands and retailers interested in identifying country-of-origin in cases of cotton fiber substitution.
LONDON, UK / ACCESSWIRE / January 16, 2018 / Active-Investors.com has just released a free earnings report on Applied DNA Sciences, Inc. (NASDAQ: APDN ) ("Applied DNA"). If you want access to ...
Applied DNA Sciences, Inc. , today announced that SigNature® DNA evidence has helped to convict a member of an Irish organized crime group involved in a Cash in Transit robbery.
On a per-share basis, the Stony Brook, New York-based company said it had a loss of 10 cents. The DNA-based security technology company posted revenue of $1.1 million in the period. For the year, the company ...
Applied DNA Sciences, Inc. , announced financial results for the full fiscal year and quarter ended September 30, 2017.
Applied DNA Sciences, Inc. , announced today it plans to release results for the fourth quarter and fiscal 2017 ended September 30, 2017 after market close on Thursday, December 28, 2017.
Applied DNA Sciences, Inc. today announced that it has entered into a securities purchase agreement with certain institutional investors to purchase an aggregate of 2,735,000 shares of common stock and warrants to purchase an aggregate of 2,735,000 shares of common stock in a registered direct offering with aggregate gross proceeds of $4,786,250, exclusive of warrant exercise proceeds.
Applied DNA Sciences, Inc. , and Colorcon, Inc. have entered into a technology license memorandum of understanding that combines Applied DNA’s proprietary molecular taggant and authentication technology with Colorcon’s portfolio of film coating systems, inks and color dispersions for use in solid oral dosage forms in the pharmaceutical and nutraceutical industries.
Applied DNA Sciences, Inc. today announced selected preliminary unaudited financial results for the full fiscal year and quarter ended September 30, 2017.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Applied DNA Sciences, Inc. Here are 5 ETFs with the largest exposure to APDN-US. Comparing the performance and risk of Applied DNA Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
Applied DNA Sciences, Inc. , today announced the renewal of their contract to provide SigNature® DNA via Safesolution SmartDNA AB, its Swedish Distributor, to a prestige German car manufacturer to prevent vehicle theft.